Archive for the ‘Martin Nutraceuticals MNIU’ Category

Beacon Equity Research Featured Company: Martin Nutraceuticals, Inc. (MNCL.PK)

Tuesday, February 26th, 2008

Martin Nutraceuticals, Inc. (MNCL.PK) develops and markets natural and complimentary medicine for aid in joint and general arthritic pain, digestion issue, blood and circulatory flow, weight control, and optimal overall functioning of the human body. The Martin Nutraceutical family has expanded to include such revolutionary products such as ArthrizymeTM, DigestzymeTM, HeartzymeTM, PetzymeTM, OxygenolTM, Maximum Slim and ProbiotixTM.

The Martin Nutraceutical Team has been active in contributing to better health care for the past decade. Accumulating a vast knowledge in the naturopathic industry, Martin Nutraceuticals has developed nutraceuticals to help improve the quality of life, in all aspects of life. Implementing the highly coveted success of Dr. Martin’s Joint Therapy, which has contributed to helping thousands of people overcome pain and suffering related to arthritis and joint pain, Martin Nutraceuticals has developed a family of innovative complimentary medicine to aid all types of difficulties to enhance a better lifestyle.

In 1989, The Foundation for Innovation in Medicine coined the term “nutraceutical” to give identity to a highly promising area of health and medicine. Since the coining of the term, the nutraceutical market has become a highly respected industry for supplement health. This market has averaged a 7% increase year over year for the last 5 years. It is estimated that in the United States, nearly 10% of the population is suffering from some sort of joint pain. It is also estimated that over 20 million Americans, mostly over the age of 45, have osteoarthritis.

By integrating proprietary oral systemic enzymes, Martin Nutraceuticals has revolutionized the consumption of naturopathic supplementation. With the use of these enzymes with products such as ArthrizymeTM, Martin Nutraceuticals has designed an innovative way to treat arthritis and general joint pain.

Let us hear your thoughts: Martin Nutraceuticals, Inc. Message Board

MNCL – Martin Nutraceuticals, Inc. Features Treatment for Arthritis

Wednesday, December 27th, 2006

The Martin Nutraceuticals signature product for the treatment of Arthritis is Arthrizyme. 

Arthrizyme differs from all other natural arthritis remedies. Arthrizyme was designed to work for all types of arthritis and in all joints of the body. Arthrizyme will rid the body of inflammation regardless of location and promote healing. Arthrizyme is fast acting, usually improving symptoms within the first few days.
Arthrizyme is a systemic oral enzyme designed to revolutionize the way arthritis is naturally treated. According to Time Magazine, we are in the age of arthritis. The Center for Disease Control (CDC) estimates that 1 in 3 Americans have arthritis and/or joint pain. In Canada, 4 million people have been diagnosed with arthritis and millions of others complain of some undiagnosed form of joint pain. 

Arthrizyme is a systemic oral enzyme designed to revolutionize the way arthritis is naturally treated. According to Time Magazine, we are in the age of arthritis. The Center for Disease Control (CDC) estimates that 1 in 3 Americans have arthritis and/or joint pain. In Canada, 4 million people have been diagnosed with arthritis and millions of others complain of some undiagnosed form of joint pain. 

Martin Nutraceuticals, Inc. Rebounds After Holiday, Up 50%

Tuesday, December 26th, 2006

Investors went shopping on the day after Christmas, and sent the shares of MNCL – Martin Nutraceuticals Up 50% for the day.

Over the past decade, MNCL has developed a large family of complimentary medicine products, that have been well received by consumers.  The product uses span general joint pain, increased activity of the immune system, alertness and awareness, and obesity control.

“Happy Holidays from QualityStocks.net”

Friday, December 22nd, 2006

Small Cap Stock Newsletter QualityStocks New Site Launched

Wednesday, December 6th, 2006
SCOTTSDALE, AZ. Small Cap Stock Newsletter QualityStocks.net has been tracking hundreds of investment newsletters since January and this week “The NEW QualityStocks.net Daily Newsletter” was delivered with great results. “Our NEW web site launched on schedule December 1st and the comments we have received to far have been outstanding.” stated Michael McCarthy, Director of Business Development with QualityStocks.net.

The following stocks were featured this week in The NEW QualityStocks.net Daily Newsletter:


Military Resale Group, Inc. (MYRG) was highlighted this month by SmallCapVoice, Traders Nation, and QualityStocks.net. Military Resale Group has a solid track record as a specialist in military distribution and following the acquisition of Pittock Distributors in 1997, MYRG’s aggressive growth strategy resulted in a nine-fold sales increase. For more than five years, has been growing the company servicing military commissaries for six military bases in Colorado, Wyoming and South Dakota. Military Resale Group has recently this year obtained the necessary elements to allow for the success of this aggressive expansion and this included internal funding, new management, new facilities and new profitable and in demand products. Military Resale Group has now opened their new office to service the North East from Boston to Washington DC.”  Military Resale Group has had a successful history selling annually as much as $5.3 million in revenue as only a regional distributor of grocery and household items to the military market. Military Resale Group has been distributing a wide variety of items, including fresh and frozen meat and poultry, seafood, frozen foods, canned and dry goods, beverages, dairy products, paper goods and cleaning and other supplies. 



Martin Nutraceuticals, Inc. (MNCL) was highlighted this month by OTC Stock Review, OTC Picks, OTC Stock Exchange, HotOTC.com, InsideMove.com, Stock Egg.com, Cash Cow Mag, Small Cap Voice, Microapaliance, Traders Nation and today by OTC Stock Exchange,Small Cap Voice and QualityStocks.net.

Martin Nutraceuticals Inc. In a press release from today cites a recent Canadian press article on Prexige, a member of the same drug class as Vioxx gaining Health Canada approval. Prexige is also a Cox-2 inhibitor which has been brought to market as a treatment for new acute and chronic pain due to osteoarthritis of the knee in adults. This Cox-2 inhibitor is from the same class of drugs that were recently pulled from the market worldwide after studies showed people on the drug were almost double the risk of heart attack and stroke than non-users of these drugs, namely – Vioxx, Celebrex and Bextra.

Martin Nutraceuticals Inc. is a development stage to the general consumer, increasing the activity of the immune system and obesity control they are focused on providing a better health and lifestyle through products. Martin Nutraceuticals’ flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control. Martin Nutraceuticals has developed a family of innovative complimentary medicine to aid all types of difficulties to enhance a better lifestyle. In the United States alone, the nutraceutical market was worth approximately $19 BIL in 2004 according to the American Nutraceutical Association and this year the market is at over 68 BIL.



Universal Travel Group (UTVG) was highlighted by Wall Street Grapevine, Small Cap Voice, OTC Picks, and OTC Financial Network this month and today by OTC Picks, Wall Street Grapevine and QualityStocks.net.

Universal Travel Group through its wholly owned subsidiary, Yu Zhi Lu Aviation Service Company Ltd. (“YZL”), is engaged in travel services pertaining to domestic and international lines through Hong Kong, Macau, and Taiwan . The Company’s core services include dynamic booking for air tickets, hotels, and restaurants, as well as tour routing for customers. It also provides hotel reservations, packaged tours, and air delivering services. The Company also provides logistical services for the specific needs of the leisure and business traveler, which include car rentals, livery services, itinerary planning, and conference management.



Nascent Wine Co. (NCTW) has been highlighted by Knobias Clip Report, Pilot Financial Communication and QualityStocks.net this month.

Nascent Wine Co. a company seeking to become one of the largest food distributorships in Mexico, announced today that it has signed a Letter of Intent to acquire a Mexico based food importing and distribution company. Acquisition will make Nascent first nationwide distributor of imported foods in Mexico. Nascent Wine Co. operates in the beverage and food industry in Mexico . Nascent Wine Co. was founded in 2002 and is based in San Diego , California. For more information please visit Nascent Wine Nascent Wine Co. Inc. is charting a course to become a leader in the beverage and food industry in Mexico . The Company is the exclusive distributor of Miller Beer in Baja California, Mexico . The Company plans to continue acquiring small- to medium-sized beverage and food distributors in Mexico.



 

Sub Surface Waste Management of Delaware Inc. (SSWM) was highlighted this month by SmallCapVoice and QualityStocks.net.

Sub Surface Waste Management announced today that it expects strong growth for its Mexico subsidiary company, Environmental Tec International, S.A. de C.V. (ETI), under the new government of President Felipe Calderon, who took office Friday promising to build an economy that creates enough jobs so that millions of Mexicans don’t have to cross into the United States.

Sub Surface Waste Management of Delaware, Inc. engages in the design, installation, and operation of proprietary soil and groundwater remediation systems for clean up of toxic waste releases to soil and groundwater, and the bio-recycling of spent activated carbon filtration media. The company’s customers include oil companies; toxic and hazardous waste treatment and disposal companies; manufacturers with fixed point source facilities, such as automotive, aerospace, and electronic component manufacturers; specialty environmental remediation companies; agricultural processors, paper and cellulose waste-stream producers, golf courses; poultry, pork, beef, and fish processors; and medical and hospitality waste-streams. Sub Surface Waste Management also provides comprehensive civil and environmental engineering project management services including specialists to design, permit, build and operate environmental waste clean-up treatment systems using conventional, biological and filtration technologies. SSWM is capitalizing on its patented technologies registered in Mexico with SEMARNAT a Federal regulatory agency overseeing environmental compliance nationwide.  



About QualityStocks.net 

QualityStocks.net is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one free Daily Newsletter Report. To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Check out our the NEW broadcast www.QualityStocksLIVE.com

 

Michael McCarthy

Director of Business Development

QualityStocks.net

www.QualityStocks.net

212-699-0748-Direct

Study Points to Problems with Arthritis Pharmaceuticals

Tuesday, December 5th, 2006

Martin Nutraceuticals Inc. (MNCL) cites a recent Canadian press article on Prexige, a member of the same drug class as Vioxx gaining Health Canada approval.

Prexige is also a Cox-2 inhibitor which has been brought to market as a treatment for new acute and chronic pain due to osteoarthritis of the knee in adults. This Cox-2 inhibitor is from the same class of drugs that were recently pulled from the market worldwide after studies showed people on the drug were almost double the risk of heart attack and stroke than non-users of these drugs, namely – Vioxx, Celebrex and Bextra.

An expert on Cox-2 inhibitors warned that all the drugs should be used with caution. “Patients at risk of heart disease should avoid all selective all selective Cox-2 inhibitors including Prexige, based on current evidence,” stated Dr. Garret FitzGerald, a cardiologist and pharmacologist at the University of Pennsylvania.

Dr. Tony Martin, Director of Research and Development for Martin Nutraceuticals, stated, “People are suffering from many forms of arthritis and because of this suffering; drugs which are not safe are being fast tracked into the marketplace. We at Martin Nutraceuticals, however offer an effective solution to these sufferers in the form of Arthrizyme, a product that is 100% natural and 100% safe. This is why Martin Nutraceuticals is becoming a valued name in helping all forms of joint pain.”

MNCL – Up 25.00 % Today

Monday, December 4th, 2006

MNCl – Martin Nutraceuticals was Up $0.05 today or 25% on volume of 20,000

 

Martin Nutraceuticals (MNCL) to Launch Infomercials

Friday, December 1st, 2006

The Company plans to benefit from an aggressive direct product marketing campaign to launch shortly.

“We are now in the final stretch of completing our corporate objective, which has been penetrating the multi-billion dollar DRTV market. Many companies have strived to accomplish a complete DRTV program, Martin Nutraceuticals is one of the few companies that has achieved this milestone. We will use this DRTV program as a launching pad that will put us in the forefront of the Nutraceutical market,” states Harvey Panesar, President of Martin Nutraceuticals Inc.

MNCL Finds Huge Global Niche in Health and Wellness

Friday, December 1st, 2006

Martin Nutraceuticals brings a broad range of products to the market, for disorders that affect millions of people worldwide. With the aging of the population and the increasing importance that consumers give to their health, the US and European market will grow tremendously. Some studies have calculated that the annual market will reach $60 billion by 2009. New research shows that Pine Bark Extract as used by MNCL Martin Nutraceuticals in its products has positive effects on the Cardiovascular System. It shows to lower blood pressure, reduce LDL cholesterol, improve microcirculation, and prevent platelet aggregation.

Dr. Martin’s New Book is Really on Target

Friday, December 1st, 2006

Dr. Tony Martin, Director of Research and Development with Martin Nutraceuticals (MNCL), was a featured speaker recently at the “Whole Life Expo” in Toronto to a “standing room only” crowd.

Dr. Martin introduced his latest book at the event; “Medical Crisis: Secrets Your Doctor Won’t Share With You”. The event is Canada’s largest showcase of natural health and alternative medicine.

The book provides great insights into the health benefits of the Company’s flagship products, Arthrizyme and Oxygenol. The book and the products will be featured in upcoming infomercials to launch in the near future.

Direct Response Television has been proven to be a very successful product marketing tool in the health, wellness, and natural supplement areas.

Welcome to our Small Cap and Micro Cap BLOG site

Friday, December 1st, 2006

We welcome visitors to an open and friendly discussion of small cap and micro cap stocks